# astrazeneca (blogs) — RSS Amplifier Recent posts from the 3 feeds in the RSS Amplifier directory that cover astrazeneca. Page: Feed: --- ## [Before its recent Phase 3 LSD win, Definium modeled up to $70,000 a year for a therapy that could fill a clinical shift](https://www.drugdiscoverytrends.com/before-its-recent-phase-3-lsd-win-definium-modeled-up-to-70000-a-year-for-a-therapy-that-could-fill-a-clinical-shift/) _2026-08-21 · Brian Buntz · Drug Discovery and Development_ New York City–based Definium recently announced positive data from its Phase 3 Voyage trial of DT120, an orally disintegrating 100 µg dose of LSD in adults with generalized anxiety disorder (GAD). The company announced positive Phase 3 results for the same compound for major depressive disorder (MDD) in June. Now the company needs to convince… The post Before its recent Phase 3 LSD win, Definium… ## [Nebenwert explodiert: Europas stärkste Rüstungsaktie 2026? Diese Aktie schlägt Rheinmetall und Saab](https://www.finanznachrichten.de/nachrichten-2026-08/69373793-nebenwert-explodiert-europas-staerkste-ruestungsaktie-2026-diese-aktie-schlaegt-rheinmetall-und-saab-049.htm) _2026-08-21 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ © Foto: Philipp Schulze - dpaMehr als 70 Prozent Kursplus seit Jahresbeginn: Dieser schwedische Spezialist profitiert von der Welle des Rüstungsbooms Enthaltene Werte: FR0000121329,DE0007030009,FR0... ## [NIBE Industrier Earnings Up In Q2](https://www.finanznachrichten.de/nachrichten-2026-08/69371451-nibe-industrier-earnings-up-in-q2-020.htm) _2026-08-21 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ STOCKHOLM (dpa-AFX) - NIBE Industrier AB (NIBEB.SW, NIABY, NIBE\_B.ST), a Swedish manufacturing company, on Friday reported higher net income in the second quarter of 2026 compared with the previou... ## [BERNSTEIN RESEARCH stuft ABB LTD auf 'Neutral'](https://www.finanznachrichten.de/nachrichten-2026-08/69371057-bernstein-research-stuft-abb-ltd-auf-neutral-322.htm) _2026-08-21 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für ABB mit einem Kursziel von 80 Franken auf "Market-Perform" belassen. Die Analysten um Varun Govindaraj ste... ## [Metabolic stability: The defining challenge for multifunctional peptides](https://www.drugdiscoverytrends.com/metabolic-stability-the-defining-challenge-for-multifunctional-peptides/) _2026-08-20 · Dr. Hanlin Tao, Haijuan Liu · Drug Discovery and Development_ The demand for peptide therapeutics has grown rapidly in recent years, as the success of GLP-1 drugs has catapulted them to the forefront of developers’ and sponsors’ minds. Although peptides still represent a relatively small share of FDA-approved therapeutics, they offer distinct advantages in treating diseases where small-molecule drugs or therapeutic antibodies fall short. The… The post… ## [Roche pours $750M into Oregon manufacturing plant as obesity push expands](https://www.biospace.com/drug-delivery/roche-pours-750m-into-oregon-manufacturing-plant-as-obesity-push-expands) _2026-08-20 · Gabrielle Masson · Drug Delivery News_ After committing $2 billion to a new North Carolina facility to boost capacity for its next-gen obesity candidates, Roche's Genentech is putting down more cash to expand a device fill-finish site in Oregon. ## [Milliarden fließen: Europa-Anlagen werden zum Erfolg - Investoren schichten um](https://www.finanznachrichten.de/nachrichten-2026-08/69367729-milliarden-fliessen-europa-anlagen-werden-zum-erfolg-investoren-schichten-um-049.htm) _2026-08-20 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ © Foto: wO-ChatGPT Jahrelang galt Europas Börsenstruktur als Nachteil. Jetzt entdecken internationale Investoren genau diese Mischung aus Industrie, Banken und moderaten Bewertungen neu. Und profit... ## [SNB klatscht Beifall: Schweizer Franken läuft Yen den Rang ab](https://www.finanznachrichten.de/nachrichten-2026-08/69367369-snb-klatscht-beifall-schweizer-franken-laeuft-yen-den-rang-ab-049.htm) _2026-08-20 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ © Foto: wO-ChatGPT Der Schweizer Franken läuft dem Yen beim Carry-Trade-Neugeschäft den Rang ab. Für die SNB und Schweizer Exporteure kommt diese Entwicklung zur richtigen Zeit Enthaltene Werte: CH... ## [Scribe’s early-stage IPO standout defies biotech’s derisking trend](https://www.biospace.com/business/scribes-early-stage-ipo-standout-defies-biotechs-derisking-trend) _2026-08-20 · Gabrielle Masson · Drug Delivery News_ Scribe Therapeutics’ one-time epigenetic treatment is designed to slash the adherence burden of chronic cholesterol-lowering therapies while sidestepping the irreversibility of gene editing. ## [Frost & Sullivan: Ericsson Earns Two Global Product Leadership Recognitions in Enterprise 5G WWAN and In-Vehicle Network Infrastructure](https://www.finanznachrichten.de/nachrichten-2026-08/69365332-frost-sullivan-ericsson-earns-two-global-product-leadership-recognitions-in-enterprise-5g-wwan-and-in-vehicle-network-infrastructure-008.htm) _2026-08-20 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ Company recognized for delivering secure, high-performance wireless connectivity through a unified platform that helps enterprises simplify operations, improve resilience, and scale distributed en... ## [Sync Bookmarks Everywhere (Sponsored)](https://crawlproof.com/a/fJt4AnPhEr3G) _2026-08-20 · **Sponsored**_ Two-way sync keeps folders and toolbar intact across Chrome, Firefox, and Safari. ## [GOLDMAN SACHS stuft ASTRAZENECA auf 'Buy'](https://www.finanznachrichten.de/nachrichten-2026-08/69360168-goldman-sachs-stuft-astrazeneca-auf-buy-322.htm) _2026-08-20 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Astrazeneca von 16070 auf 16300 Pence angehoben und die Einstufung auf "Buy" belassen. Analyst Rajan Sharma wi... ## [As 59% fewer pharma companies cut staff in Q2 in 2026, job postings rise 15%](https://www.drugdiscoverytrends.com/as-59-fewer-pharma-companies-cut-staff-in-q2-in-2026-job-postings-rise-15/) _2026-08-20 · Brian Buntz · Drug Discovery and Development_ 2022 was a big year for layoffs in biopharma. So were the next three. Novartis, for instance, outlined plans to cut up to 8,000 jobs in 2022, after pharmaceutical industry job cuts jumped 280% in 2021. Biogen followed in 2023 with a “Fit for Growth” program that put roughly 1,000 roles on the block. Bristol… The post As 59% fewer pharma companies cut staff in Q2 in 2026, job postings rise 15%… ## [Wolfram-Schock für Sandvik und Lockheed Martin - Almonty mit perfekter Ausgangslage](https://www.finanznachrichten.de/nachrichten-2026-08/69358683-wolfram-schock-fuer-sandvik-und-lockheed-martin-almonty-mit-perfekter-ausgangslage-673.htm) _2026-08-20 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ Wenn Rüstungsgüter oder Industriewerkzeuge an ihre Leistungsgrenzen stoßen, hilft oft ein gefragtes Schwermetall weiter: Wolfram widersteht mit seinem Schmelzpunkt von 3.422 °C selbst enormer Hitze... ## [Essity acquires feminine care business in Brazil](https://www.finanznachrichten.de/nachrichten-2026-08/69358599-essity-acquires-feminine-care-business-in-brazil-008.htm) _2026-08-20 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ STOCKHOLM, Aug. 20, 2026 /PRNewswire/ -- Hygiene and health company Essity has entered into an agreement to acquire Kenvue's feminine care business in Brazil, including the market-leading brands C... ## [Buy or Goodbye?: Tesla, Porsche AG, Astrazeneca und DocMorris - Die Analystenstimmen des Tages](https://www.finanznachrichten.de/nachrichten-2026-08/69353508-buy-or-goodbye-tesla-porsche-ag-astrazeneca-und-docmorris-die-analystenstimmen-des-tages-049.htm) _2026-08-19 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ © Foto: Tesla - Tesla.comTesla, Porsche AG, Astrazeneca und DocMorris: Die wichtigsten Analysten-Updates im Überblick Enthaltene Werte: GB0009895292,US88160R1014,CH0042615283,DE000PAG9113Den vollst... ## [DEUTSCHE BANK RESEARCH stuft ASTRAZENECA auf 'Sell'](https://www.finanznachrichten.de/nachrichten-2026-08/69350613-deutsche-bank-research-stuft-astrazeneca-auf-sell-322.htm) _2026-08-19 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca mit einem Kursziel von 11500 Pence auf "Sell" belassen. Dies schrieb Emmanuel Papadakis in seiner am Mittwoc... ## [UBS stuft ASTRAZENECA auf 'Buy'](https://www.finanznachrichten.de/nachrichten-2026-08/69348587-ubs-stuft-astrazeneca-auf-buy-322.htm) _2026-08-19 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca mit einem Kursziel von 17600 Pence auf "Buy" belassen. Nach dem Scheitern des Wirkstoffs Wainua im Einsatz ... ## [UBS stuft H&M auf 'Neutral'](https://www.finanznachrichten.de/nachrichten-2026-08/69348192-ubs-stuft-h-m-auf-neutral-322.htm) _2026-08-19 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für H&M nach Quartalzahlen mit einem Kursziel von 168 schwedischen Kronen auf "Neutral" belassen. Die Textilkette entwickle... ## [Nordea Bank Abp: Changes in Nordea's Group Leadership Team](https://www.finanznachrichten.de/nachrichten-2026-08/69348955-nordea-bank-abp-changes-in-nordea-s-group-leadership-team-399.htm) _2026-08-19 · FinanzNachrichten.de: Nachrichten zu Schweden 30_ Nordea Bank Abp Stock exchange release - Changes board/management/auditors 19 August 2026 at 9.00 EET Nordea announces changes to its Group Leadership Team with appointments in Personal Banking an... ## [How Sheba Medical Center became OpenAI’s first international hospital partner](https://www.drugdiscoverytrends.com/how-sheba-medical-center-became-openais-first-international-hospital-partner/) _2026-08-18 · Brian Buntz · Drug Discovery and Development_ OpenAI’s first international hospital partnership is taking shape at a giant medical center where English is not the default language and where the electronic health record does not come from Epic, the dominant U.S. EHR vendor. That institution is Sheba Medical Center, the Israel-based medical center with its own 50-plus-person AI Center within ARC, its… The post How Sheba Medical Center became… ## [Marketplace for AI-Powered Professionals (Sponsored)](https://crawlproof.com/a/PV5LzGgVg5DS) _2026-08-18 · **Sponsored**_ Find professionals who use ChatGPT, Copilot, and Claude to deliver work faster. ## [FDA issues final PDUFA meeting guidance, expands use of written responses](https://www.drugdiscoverytrends.com/fda-issues-final-pdufa-meeting-guidance-expands-use-of-written-responses/) _2026-08-18 · Julia Rock-Torcivia · Drug Discovery and Development_ The FDA has finalized new guidelines for meetings between the FDA and sponsors or applicants relating to the development and review of drugs or biological products under the Prescription Drug User Fee Act (PDUFA). The FDA first published the draft guidance on Sept. 22, 2023, when it collected public comment on the guidelines. The final guidelines contain several changes from the draft, including… ## [Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars](https://www.biospace.com/drug-delivery/sandoz-inks-322m-henlius-deal-for-rights-to-as-many-as-10-biosimilars) _2026-08-18 · Nick Paul Taylor · Drug Delivery News_ The initial batch of biosimilars includes copies of Amgen, Eli Lilly and GSK drugs that collectively generate billions of dollars in annual revenues. ## [Gilead and Nucleai probe why target-positive tumors can still resist ADCs](https://www.drugdiscoverytrends.com/gilead-and-nucleai-probe-why-target-positive-tumors-can-still-resist-adcs/) _2026-08-18 · Brian Buntz · Drug Discovery and Development_ Antibody-drug conjugates (ADCs) have emerged as one of the busiest and most crowded niches within oncology, given their potential to use an antibody to ferry a potent cytotoxic payload toward tumor cells. The class now spans about 15 FDA-approved products, and the segment is growing steadily. Evaluate Pharma projects the ADC category will reach $57… The post Gilead and Nucleai probe why… ## [Schrödinger-BMS collaboration centers on Bunsen for trillion-scale computational drug discovery](https://www.drugdiscoverytrends.com/schrodinger-bms-collaboration-centers-on-bunsen-for-trillion-scale-computational-drug-discovery/) _2026-08-17 · Brian Buntz · Drug Discovery and Development_ The 1990-founded scientific software firm Schrödinger recently announced a strategic collaboration and software agreement with Bristol Myers Squibb (BMS) built around Bunsen, Schrödinger’s newly announced agentic AI co-scientist. While the term “AI co-scientist” can have varying definitions, Schrödinger is positioning Bunsen as a sort of execution engine for computational chemistry, including… ## [The 50 best-funded biotech companies of 2026](https://www.drugdiscoverytrends.com/the-50-best-funded-biotech-companies-of-2026/) _2026-08-13 · Brian Buntz · Drug Discovery and Development_ By one measure, Alphabet-controlled Isomorphic Labs would tower over every company on this list. The AI drug discovery company has raised $2.7 billion in external financing, including a $2.1 billion Series B announced in May. Its corporate structure, however, puts it outside our definition of an independent biotech startup: Alphabet still controls at least 75%… The post The 50 best-funded biotech… ## [New cell imaging method reveals hidden enzyme activity](https://www.drugdiscoverytrends.com/new-cell-imaging-method-reveals-hidden-enzyme-activity/) _2026-08-13 · Julia Rock-Torcivia · Drug Discovery and Development_ Negative biosensors have often been unusable because, as the sensors lose signal when activity is detected, regions of high enzyme activity can look identical to regions with no activity. Researchers at the University of Illinois Chicago have solved this problem with a new cell imaging method that allows scientists to see previously hidden enzyme activities by flipping the optical readout of… The… ## [HHS seeks nominees for vaccine advisory panel with $757K estimated annual cost after almost two years without a meeting](https://www.drugdiscoverytrends.com/hhs-seeks-nominees-for-vaccine-advisory-panel-with-757k-estimated-annual-cost-after-almost-two-years-without-a-meeting/) _2026-08-13 · Julia Rock-Torcivia · Drug Discovery and Development_ The Department of Health and Human Services (HHS) is soliciting nominations for appointment to the National Vaccine Advisory Committee (NVAC), the agency said in a notice published Wednesday. A renewed NVAC charter filed in July estimates the committee’s annual operating cost at $756,918 and calls for staff support equivalent to two full-time employees. The committee has not met since September… ## [Novo Nordisk’s ziltivekimab misses Phase 3 primary endpoint](https://www.drugdiscoverytrends.com/novo-nordisks-ziltivekimab-misses-phase-3-primary-endpoint/) _2026-08-12 · Julia Rock-Torcivia · Drug Discovery and Development_ Novo Nordisk’s ziltivekimab, an investigational human monoclonal antibody that targets the IL-6 ligand, a pro-inflammatory cytokine, to reduce cardiovascular inflammation, did not reduce the risk of major adverse cardiovascular events (MACE) in a Phase 3 trial. “Although ziltivekimab produced the expected biological effect, this did not result in MACE benefits in this population,” Martin Holst… ## [FDA rejects ITM Isotope’s radiopharma therapy over manufacturing issues](https://www.biospace.com/fda/fda-rejects-itm-isotopes-radiopharma-therapy-over-manufacturing-issues) _2026-08-11 · Gabrielle Masson · Drug Delivery News_ ITM Isotope Technologies plans on resubmitting its advanced cancer radiopharma therapy to the FDA after addressing the agency’s concerns. ## [Scholar Rock rejigs approval filing after FDA flags violations at Novo plant](https://www.biospace.com/fda/scholar-rock-rejigs-approval-filing-after-fda-flags-violations-at-novo-plant) _2026-08-11 · Nick Paul Taylor · Drug Delivery News_ Despite earlier claims of improvement at the fill-finish plant, the FDA has classified the facility as Official Action Indicated based on inspection findings. ## [Browse ThreatCrush Modules (Sponsored)](https://crawlproof.com/a/y1JkBUcfz6pU) _2026-08-11 · **Sponsored**_ Install community-built security modules to extend real-time threat intelligence and monitoring ## [BMS picks Texas for new $2.3B manufacturing campus](https://www.biospace.com/drug-delivery/bms-picks-texas-for-new-2-3b-manufacturing-campus) _2026-08-10 · Gabrielle Masson · Drug Delivery News_ Bristol Myers Squibb’s $2.3 billion Houston manufacturing campus is part of the company’s larger $40 billion investment designed to bolster American innovation and manufacturing. ## [AstraZeneca partners with CSPC to build Chinese biologics manufacturing plant](https://www.biospace.com/drug-delivery/astrazeneca-partners-with-cspc-to-build-chinese-biologics-manufacturing-plant) _2026-08-10 · Nick Paul Taylor · Drug Delivery News_ News of the joint venture comes months after AstraZeneca vowed to spend $15 billion in China by the end of the decade. ## [From ex vivo to in vivo: Shaping the next generation of viral vector manufacturing](https://www.biospace.com/drug-development/from-ex-vivo-to-in-vivo-shaping-the-next-generation-of-viral-vector-manufacturing) _2026-08-10 · Jennifer C. Smith-Parker · Drug Delivery News_ The shift from ex vivo to in vivo gene delivery is rewriting the rules of viral vector manufacturing, forcing developers to rethink scale, purity, cell lines and analytics as vectors themselves become the drug. AGC Biologics is betting on stable producer lines, next‑gen purification and deeper characterization to meet the far stricter demands of in vivo therapies. ## [Biologics push CMOs/CDMOs to expand sterile fill-finish and prefilled syringe capacity](https://www.biospace.com/drug-development/biologics-push-cmos-cdmos-to-expand-sterile-fill-finish-and-prefilled-syringe-capacity) _2026-08-03 · Jennifer C. Smith-Parker · Drug Delivery News_ As biologics, biosimilars and GLP-1s drive demand for sterile drug products, CMOs and CDMOs are investing in fill-finish, lyophilization, inspection and packaging capacity to keep pace with a dynamic injectable market. ## [Merck dives into cholesterol with first FDA approval for oral PCSK9 inhibitor](https://www.biospace.com/fda/merck-dives-into-cholesterol-with-first-fda-approval-for-oral-pcsk9-inhibitor) _2026-07-16 · Gabrielle Masson · Drug Delivery News_ Merck’s once-daily pill is the first oral PCSK9 inhibitor to hit the market for high cholesterol, beating AstraZeneca in the race to develop more accessible treatment options.